Member Info for Vascular

13.28 to buy 50,000 on IG.

I wonder how many of todays trades are not showing on LSE Today.

I made 5 trades today at 13.48pm onwards over 3 minutes. 3 x 10k trades at 12.4p and 1 x 20k trades at 12.94p - none of them showing!

Details of the NHS frontline digital productivity programme leaked online!

The Frontline Productivity (FP) programme, which is expected to launch in April, will succeed the Frontline Digitisation programme, which aimed to support NHS trusts to reach a core level of digitisation, when it ends in March.

If you click on the blue highlighted word “ Slides” you get the leaked slides. Looking good. cheers Vas

https://www.digitalhealth.net/2026/01/details-of-nhs-digital-productivity-programme-leaked-online/

I may have misunderstood the following info but FDBK have recently stated in September presentation something about having to wait for funding decision, could be anytime up until March 26 etc..something about

“Spending review funding for NHS frontline for 2026-2027….”

This was published in Nov 25. its a scrutiny document / process relating to new funding named as “Frontline Digitisation Programme “ and leads to a good conclusion , in confirming it will lead to value for money with this stated” I am clear that the ‘preferred option’ that is set out is proper, regular, feasible and offers good value for money. This summary sets out the key points which informed my approval decision.”

And

“ The programme has been subject to ongoing IPA assurance. A final IPA Gate 5 Review is planned for February 2026. The reviews to date have recognised the progress to mobilise the programme across NHS trusts and the well-developed organisation, governance arrangements and proportionate assurance framework.”

https://www.gov.uk/government/publications/department-of-health-and-social-care-accounting-officer-assessments/frontline-digitisation-programme-accounting-officer-assessment#:~:text=Feasibility,information%20sharing%20within%20the%20programme.

So if this does pertain to the funding mentioned by FDBK then we are getting close.

I can’t find anywhere that stipulates that Alcidions products have medical device certification in UK. Bleepa we understand does, and is either the only one available or one of a very few.

On a AI search it states

Software that performs a medical purpose, such as diagnosing, monitoring, or treating a medical condition, is classified as a medical device. Alcidion's solutions, such as Miya Results, Miya Observations, and Miya Precision, are software-based platforms used by clinicians for tasks like tracking test results, recording vital signs, and managing patient flow. “

To me Bleepa and Myra etc products are different, achieve different objectives and registered differently.

iMO This modular system is a build it as you go , where Bleepa or other interoperable solutions can be added at any stage when required.

Hi Rebarm,

This article may help. Cheers Vas

https://www.alcidion.com/news/reimagining-eprs-for-2030/#:~:text=The%20cultural%20shift%20is%20from,to%20platform%20as%20a%20partnership.&text=At%20Alcidion%2C%20our%20philosophy%20is,actionable%2C%20real%2Dtime%20insights.

Thanks Bill

Who know, could be important . The key phrase imo is…

“ Hospitals across Sussex are preparing for a major digital upgrade designed to improve patient safety and provide more joined-up care.

University Hospitals Sussex (UHSussex) has selected a supplier to deliver a new electronic patient record (EPR) system across all of its hospitals, marking a key milestone in the Trust’s long-term Excellent Care Everywhere strategy.”

Note….“ to deliver a EPR system across All of its hospitals”

As we know QVH along with FDBK medical is continuing their work and extending the Bleepa reach and pathway's to community and other hospitals, possibly. This was discussed at the Sept 25 Q&A…..It could be used as a blueprint for national rollout possibly, but NHS wanted more connections and pathways .

The seven NHS provider partners in the Sussex Health and Care system are:

University Hospitals Sussex NHS Foundation Trust

East Sussex Healthcare NHS Trust

Queen Victoria Hospital NHS Foundation Trust

Surrey and Sussex Healthcare NHS Trust

Sussex Partnership NHS Foundation Trust

Sussex Community NHS Foundation Trust

South East Coast Ambulance Service NHS Foundation Trust

Hard to imagine that FDBK not involved at some point. Providers can use more than one EPR as long as they are interoperable…FDBK will hopefully provide the glue to allow them to securely communicate with each other.

https://www.sussex.ics.nhs.uk/about-sussex-health-and-care/who-we-are/

Alcidion is the EPR company that has been selected as preferred EPR supplier by University Hospitals Sussex

https://hospitaltimes.co.uk/alcidion-selected-as-preferred-epr-supplier-by-university-hospitals-sussex/

Digital Health News asked health tech suppliers to share their takes on what they believe 2026 will bring.

Read on for their predictions and expectations for the year ahead:

“Shaun O’Hanlon, chief executive, Optum (UK)

“Technology will be the engine driving delivery of the NHS 10 year health plan, enabling care to move beyond hospital walls through interoperability, care coordination, and data-driven patient pathways.

“We’ll see a revolution in diagnostics and elective care, with intelligent, out-of-hospital pathways tackling waiting lists at their source in a more patient-centric and cost-conscious way.

“Community pharmacies will increasingly function as local health hubs, integrated into care pathways and empowering independent prescriber pharmacists to help balance demand.

“Underpinning all of this will be next-generation AI — safer, transparent, and supported by strong governance and human oversight — driving productivity and better patient outcomes. 2026 will see technology delivering measurable impact, reshaping care delivery at scale.”

Also interesting comments from Sentra…

“ Chris Scarisbrick, deputy UK managing director, Sectra

“Imaging will be the pressure point in 2026. Pervasive workforce shortages and capacity challenges means it is an imperative to make imaging faster, more connected, and more intelligent.

“AI will accelerate this transformation in part, but only if NHS systems and networks can confidently embrace fast-paced and at-scale deployment, learning from regions that have already excelled.

“But real progress goes beyond sprinkling algorithms into radiologists’ workflows, especially at a time when diagnostic modernisation will be the make-or-break factor in NHS reform.

“This demands a step change in diagnostic maturity, inter-disciplinary connectivity, and a willingness to modernise the underlying platforms that bind everything together.

“The UK is already seeing impact where integrated diagnostics has been adopted in earnest: productivity jumps, clinical collaboration strengthens, and patient pathways speed up. In 2026, the organisations that break remaining silos will be the ones that move the needle.”

https://www.digitalhealth.net/2026/01/2026-predictions-health-tech-suppliers-have-their-say/

Hi Dr, Most of my confidence in investing here is that we are informed that Bleepa is the only comprehensive solution in one package. If this was not the case, I would not be here.

We know FDBK have been involved with project Cortisone for a long time and were informed in Sept 25 that we were awaiting further progress after a period of silence. Im reassured that FDBK have had prior involvement with Cortisone before this latest contract award to find a consultant to put the deal together.

Nothing guaranteed of course, is it ever.GL vas

More info here.

https://www.openaccessgovernment.org/uk-awards-2-5m-contract-to-transform-deployed-military-healthcare/203142/

Interestingly, it states

“ One of the key features of Project Mercury is its robust offline capability. By leveraging Near Field Communication (NFC) technology, clinicians can securely transfer patient data between devices without an internet connection.”

I recall Bleepa in India also had stated that Bleepa could “;

“ An imaging pathway will ensure that x-rays can be transmitted even without networked connectivity, thanks to Bleepa’s cloud-hosted infrastructure.”

https://www.digitalhealth.net/2021/12/feedback-expands-cloud-based-tb-programme-in-rual-india/

Avenue3 , as the consultants will need to pull together technology ( remit, is from SMEs) from different company’s so to achieve the tenders goals. Let’s hope they choose Bleepa, as part of the solution.

Looks like some movement regarding the military Cortisone opportunity with a contract award yesterday via Project Mercury which is part of Operation Cortisone. “Project Mercury application will enable military clinicians to view, record and share medical data on multiple devices whilst on global deployments, including in the most remote of locations where an internet connection isn’t possible. “

“News story

£2.5 million contract to revolutionise deployed military healthcare

Defence Medical Services awards £2.5 million contract to Avenue3 for Project Mercury, enabling secure military medical records access worldwide.”

https://www.gov.uk/government/news/25-million-contract-to-revolutionise-deployed-military-healthcare

The contract was awarded to Avenue3

“Why choose Avenue3?

Avenue3 is the UK’s leading openEHR consultancy. We help healthcare organisations connect systems, take control of their data and deliver lasting results, improving care, reducing risk and future-proofing digital investments. “

A consultancy company that specialise in OpenEHR which is a standard FDBK solutions utilise.

https://avenue3.com/openehr

More accurately , it seems both EMIS ( Optum) and TPP cover most GP practices in UK.

Key Provider Software

EMIS Web (Optum): Used by around 58% of GP practices in England. It is a robust clinical record system integrated with the GP Connect APIs.

TPP SystmOne: Used by most of the remaining practices, it has a single central record store across all GPs using the system. TPP was the first supplier to achieve a full national rollout for some GP Connect capabilities.

Medicus Health: A smaller, newer provider that has also achieved full rollout approval for several GP Connect services.

If in the future FDBK do win to supply nationally, then any early work , trials with Optum would mean thatFDBK would also need to be included in the other providers such as TPP, I guess.

Thanks for this Bill.

This sector ( GP Connect) is heating up, and is a small, niche area, with limited competition imo. the value in Optum is the recently ( 18 months ago) bought company EMIS that is only one of only four company's in UK NHS that provides the software for , and link up GP Connect. As posted before the other three are TPP, FoT and Medicus , as far as i can see.

We know FDBK are working with Optum and if this deal does go through , and Optum is sold to TPG - this could open up doors in USA one day.

TPG could get access to both GP Connect and possibly neighbourhood Health services in UK.

Things seem to be moving along faster these days.....

Just to add on IG the largest volume trade today was 200k shares…..so how come these millions appeared here but not on IG, it’s usually the other way around in my experience….

Please forgive me with what probably sounds like a dumb question but where do all these shares ..approx 4 million today , go-once sold? And what will they do with them? From what I can see no one is buying millions of shares and if they are these buys do not appear on LSE.

Someone must receive them, and pay the seller and in doing so become the new proud owners ….surely the MMs would not accumulate so many for no good reason and if it is the MMs they have been doing this for ages…they say for each seller there is a buyer…so where are the mega buys to balance out all these sells….they have to appear somewhere, at sometime ,surely.

I don’t expect the recent buying from the CEO, & CFO is an investment as such, as far too small and could have bought cheaper ….but I do take these buys as potentially a signal to the market that potentially things are going to plan/ even on track according to opportunities presented at last investor presentation in September ?, which admittedly was down beat for rest of 2025 until first few months of 26, but did have several potential near term opportunities that could arrive between then and this quarter. We will see . I’m no expert . Gl vas

I do hope so Bill.

I am hoping for a repeat of events that happened in Oct 24. On the 16 th oct FDBK announced

“ that the Diagnostic Enhanced Advice and Guidance diversions achieved through the Bleepa platform are now eligible for reimbursement under the Elective Recovery Fund ("ERF") and that any Integrated Care Board ("ICB") or hospital in England will, with immediate effect be able to utilise this funding, by local agreement, to reimburse expenditure on the Bleepa technology.”

This announcement meant that Bleepa had been chosen as an NHS supplier and was available nationally , funded locally, and reimbursed to hospital or PCT. The share price rose to 60 p.

This award / mechanism was subsequently scrapped awaiting the elections and the SP dived, and has not recovered since. IMO this was not FDBKs fault and out of their control.

I am confident that Bleepa , which was selected as a national solution for communication between primary and secondary care in Oct 2024 , can do the same again, procured centrally this time .

We continue to be reassured by Tom that Bleepa still has no competition. Therefore the opportunity remains.

If and when Bleepa is selected the SP should react in a similar way and possibly way beyond as the rollout progresses. If Bleepa can nail this …..the opportunities in UK could be just the beginning as digitalisation of health is happening across the world and will have the same effects as how digitalisation changed banking , retail and entertainment industry’s.

Just need that first positive announcement and this share will be off like a rocket.GL vas

That’s three people very close to the company who have bought shares in the past ten days..the CEO, CFO and Jonathan David Selby Cranston…must be a good reason!

I’m finding it confusing but basically from what I can see is that FDBK, Optum and led by PPL are together going for business in neighbouring health services and as a separate approach FDBK and Optum also going for GP connect .

From 25 tear end results

“MOU signed with primary care solutions partner and NHS trust providing significant opportunities linked to the government’s neighbourhood health model” …Optum and PPL

“Commenced integration of Bleepa® with key NHS referral systems to provide greater scalability”. GP connect with Optum.

Have a look at this link. Scroll down to

Status, service level and current usage

Look out for Optum “ Live - Optum and TPP, FoT ready - Medicus “. …..association with TPP and Medicus. Is this a consortium, I have no idea.

https://digital.nhs.uk/services/gp-connect

Optum, TPP and Medicus along with ox.dh and the flower Lilly are all

GP patient record system suppliers…just five listed.

https://digital.nhs.uk/services/gp-connect/supplier-progress

Read this page. This is a big deal, dealing with the national rollout of GP connected services.

And is a list of approved GP patient record system suppliers

The second supplier down is Optum and it states” Full roll-out approved”

Then, scroll down to Consumer supplier progress

“These suppliers provide GP Connect integration to primary and secondary care services throughout the NHS. These are the products that allow NHS 111, extended access centres and more to view detailed patient records and book GP appointments remotely. “

Notice Feedback Medical listed.

So , we now have links between Optum and FDBL in neighbourhood health services (simulations) and here also with GP connect , where Optum seem to have been green lit.

https://digital.nhs.uk/services/gp-connect/supplier-progress

This page last edited 6th Nov.25